225 related articles for article (PubMed ID: 32119073)
1. Feature set optimization in biomarker discovery from genome-scale data.
Fortino V; Scala G; Greco D
Bioinformatics; 2020 Jun; 36(11):3393-3400. PubMed ID: 32119073
[TBL] [Abstract][Full Text] [Related]
2. Improved NSGA-II algorithms for multi-objective biomarker discovery.
Cattelani L; Fortino V
Bioinformatics; 2022 Sep; 38(Suppl_2):ii20-ii26. PubMed ID: 36124794
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five supervised feature selection algorithms leading to top features and gene signatures from multi-omics data in cancer.
Bhadra T; Mallik S; Hasan N; Zhao Z
BMC Bioinformatics; 2022 Apr; 23(Suppl 3):153. PubMed ID: 35484501
[TBL] [Abstract][Full Text] [Related]
4. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
[TBL] [Abstract][Full Text] [Related]
5. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
Ali M; Khan SA; Wennerberg K; Aittokallio T
Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
[TBL] [Abstract][Full Text] [Related]
6. MEvA-X: a hybrid multiobjective evolutionary tool using an XGBoost classifier for biomarkers discovery on biomedical datasets.
Panagiotopoulos K; Korfiati A; Theofilatos K; Hurwitz P; Deriu MA; Mavroudi S
Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37326976
[TBL] [Abstract][Full Text] [Related]
7. -Omics biomarker identification pipeline for translational medicine.
Bravo-Merodio L; Williams JA; Gkoutos GV; Acharjee A
J Transl Med; 2019 May; 17(1):155. PubMed ID: 31088492
[TBL] [Abstract][Full Text] [Related]
8. Identifying interactions in omics data for clinical biomarker discovery using symbolic regression.
Christensen NJ; Demharter S; Machado M; Pedersen L; Salvatore M; Stentoft-Hansen V; Iglesias MT
Bioinformatics; 2022 Aug; 38(15):3749-3758. PubMed ID: 35731214
[TBL] [Abstract][Full Text] [Related]
9. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
[TBL] [Abstract][Full Text] [Related]
10. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
11. Robustness of chemometrics-based feature selection methods in early cancer detection and biomarker discovery.
Lee HW; Lawton C; Na YJ; Yoon S
Stat Appl Genet Mol Biol; 2013 Mar; 12(2):207-23. PubMed ID: 23502343
[TBL] [Abstract][Full Text] [Related]
12. A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data.
Swan AL; Stekel DJ; Hodgman C; Allaway D; Alqahtani MH; Mobasheri A; Bacardit J
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S2. PubMed ID: 25923811
[TBL] [Abstract][Full Text] [Related]
13. MERIDA: a novel Boolean logic-based integer linear program for personalized cancer therapy.
Lenhof K; Gerstner N; Kehl T; Eckhart L; Schneider L; Lenhof HP
Bioinformatics; 2021 Nov; 37(21):3881-3888. PubMed ID: 34352075
[TBL] [Abstract][Full Text] [Related]
14. FSR: feature set reduction for scalable and accurate multi-class cancer subtype classification based on copy number.
Wong G; Leckie C; Kowalczyk A
Bioinformatics; 2012 Jan; 28(2):151-9. PubMed ID: 22110244
[TBL] [Abstract][Full Text] [Related]
15. Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.
Zhang Z; Liu ZP
BMC Med Genomics; 2021 Aug; 14(Suppl 1):112. PubMed ID: 34433487
[TBL] [Abstract][Full Text] [Related]
16. Multi-kernel linear mixed model with adaptive lasso for prediction analysis on high-dimensional multi-omics data.
Li J; Lu Q; Wen Y
Bioinformatics; 2020 Mar; 36(6):1785-1794. PubMed ID: 31693075
[TBL] [Abstract][Full Text] [Related]
17. CaPSSA: visual evaluation of cancer biomarker genes for patient stratification and survival analysis using mutation and expression data.
Jang Y; Seo J; Jang I; Lee B; Kim S; Lee S
Bioinformatics; 2019 Dec; 35(24):5341-5343. PubMed ID: 31228188
[TBL] [Abstract][Full Text] [Related]
18. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
[TBL] [Abstract][Full Text] [Related]
19. Consistent metagenomic biomarker detection via robust PCA.
Alshawaqfeh M; Bashaireh A; Serpedin E; Suchodolski J
Biol Direct; 2017 Jan; 12(1):4. PubMed ID: 28143486
[TBL] [Abstract][Full Text] [Related]
20. Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.
Klammer M; Dybowski JN; Hoffmann D; Schaab C
PLoS One; 2015; 10(6):e0128542. PubMed ID: 26083411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
